Open AccessNrf2 in liver toxicology
Author(s) -
Keiko Taguchi,
Thomas W. Kensler
Publication year - 2019
Publication title -
archives of pharmacal research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.855
H-Index - 87
eISSN - 1976-3786
pISSN - 0253-6269
DOI - 10.1007/s12272-019-01192-3
Subject(s) - toxicant , detoxication , keap1 , pharmacology , toxicology , biology , drug metabolism , detoxification (alternative medicine) , drug , transcription factor , computational biology , chemistry , toxicity , enzyme , gene , biochemistry , medicine , alternative medicine , organic chemistry , pathology
Liver plays essential roles in the metabolism of many endogenous chemicals and exogenous toxicants. Mechanistic studies in liver have been at the forefront of efforts to probe the roles of bioactivation and detoxication of environmental toxins and toxicants in hepatotoxicity. Moreover, idiosyncratic hepatoxicity remains a key barrier in the clinical development of drugs. The now vast Nrf2 field emerged in part from biochemical and molecular studies on chemical inducers of hepatic detoxication enzymes and subsequent characterization of the modulation of drug/toxicant induced hepatotoxicities in mice through disruption of either Nrf2 or Keap1 genes. In general, loss of Nrf2 increases the sensitivity to such toxic chemicals, highlighting a central role of this transcription factor and its downstream target genes as a modifier to chemical stress. In this review, we summarize the impact of Nrf2 on the toxicology of multiple hepatotoxicants, and discuss efforts to utilize the Nrf2 response in predictive toxicology.